Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure Journal Article

   

Authors:	Ball, B. J.; Famulare, C. A.; Stein, E. M.; Tallman, M. S.; Derkach, A.; Roshal, M.; Gill, S. I.; Manning, B. M.; Koprivnikar, J.; McCloskey, J.; Testi, R.; Prebet, T.; Al Ali, N. H.; Padron, E.; Sallman, D. A.; Komrokji, R. S.; Goldberg, A. D.
Article Title:	Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Journal Title:	Blood Advances
Volume:	4
Issue:	13
ISSN:	2473-9529
Publisher:	American Society of Hematology
Date Published:	2020-07-14
Start Page:	2866
End Page:	2870
Language:	English
DOI:	10.1182/bloodadvances.2020001482
PUBMED:	32589727
PROVIDER:	scopus
PMCID:	PMC7362378
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088699290&doi=10.1182%2fbloodadvances.2020001482&partnerID=40&md5=4d2c6da9aba713fadb9944cc88ad5d7a
Notes:	Article -- Export Date: 1 September 2020 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169729